Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Functionality of probiotics - potential for product development.

James Dekker1, Michael Collett, Jaya Prasad

  • 1Fonterra Co-operative Group, Palmerston North, New Zealand.

Forum of Nutrition
|August 9, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early life treatment with Lacticaseibacillus rhamnosus strains drives reduced enteric methane emissions in dairy heifers.

Journal of animal science and biotechnology·2026
Same author

The effect of milk fat globule membrane phospholipid supplementation on cognitive function in older adults with subjective memory complaints-a randomized, double-blind, placebo-controlled trial.

The American journal of clinical nutrition·2025
Same author

Outer radial glia promotes white matter regeneration after neonatal brain injury.

Cell reports. Medicine·2025
Same author

Precision Psychobiotics for Gut-Brain Axis Health: Advancing the Discovery Pipelines to Deliver Mechanistic Pathways and Proven Health Efficacy.

Microbial biotechnology·2025
Same author

Chronic Inflammation Offers Hints About Viable Therapeutic Targets for Preeclampsia and Potentially Related Offspring Sequelae.

International journal of molecular sciences·2024
Same author

Dietary gangliosides rescue GM3 synthase deficiency outcomes in mice accompanied by neurogenesis in the hippocampus.

Frontiers in neuroscience·2024

Live lactic acid bacteria offer health benefits, but strain-specific efficacy proof is crucial. Research on Bifidobacterium lactis HN019 and Lactobacillus rhamnosus HN001 demonstrates their safety and immune-modulating effects, supporting their use in functional foods.

Area of Science:

  • Microbiology
  • Immunology
  • Food Science

Background:

  • Consumer acceptance of live lactic acid bacteria for health benefits is growing.
  • Not all probiotic bacteria are equal; strain-specific efficacy must be proven.
  • Fonterra developed proprietary strains Bifidobacterium lactis HN019 and Lactobacillus rhamnosus HN001.

Purpose of the Study:

  • To review the development and evidence supporting Bifidobacterium lactis HN019 and Lactobacillus rhamnosus HN001.
  • To discuss the importance of strain-specific efficacy and the role of biomarkers in probiotic research.
  • To highlight advancements in understanding probiotic mechanisms for targeted functional foods.

Main Methods:

  • Review of peer-reviewed published reports on safety and efficacy studies.

Related Experiment Videos

  • Analysis of animal and human trials, including immune marker modulation.
  • Examination of clinical trial data and biomarker research in probiotics.

    • Main Results:

    • Bifidobacterium lactis HN019 and Lactobacillus rhamnosus HN001 have demonstrated safety in human and animal trials.
    • These strains show protection against pathogens and modulate immune markers.
    • Efficacy has been shown in human clinical trials, leading to their application in functional foods.

    Conclusions:

    • Strain-specific research is essential for validating probiotic health claims.
    • Biomarkers are necessary for screening and defining probiotic utility, though their accuracy requires further investigation.
    • Technological advances are improving the understanding of probiotic mechanisms, aiding the development of targeted, safe, and effective functional foods.